For: | Zhao YR, Wang XJ, Zhu MJ, Chen AL, Zhang D, Du Q, Kim JJ, Hu WL. Efficacy and safety of low-dose tetracycline, amoxicillin quadruple therapy in Helicobacter pylori infection: A retrospective single center study. World J Gastroenterol 2024; 30(39): 4295-4304 [PMID: 39492823 DOI: 10.3748/wjg.v30.i39.4295] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v30/i39/4295.htm |
Number | Citing Articles |
1 |
Barathan Muttiah, Wathiqah Wahid, Asif Sukri, Alfizah Hanafiah. Towards Effective Helicobacter pylori Eradication: Emerging Therapies in the Wake of Antibiotic Resistance. International Journal of Molecular Sciences 2025; 26(13): 6064 doi: 10.3390/ijms26136064
|
2 |
András Gelley, Noémi Kéri, Péter Birinyi, Kinga Komka, Vajk Hardy, László Döngölő, Dóra Szeli, Ibolya Czegle. Optimizing the Routine Use of Clinical Guidelines by Addition of Supplements (Probiotics and/or Bismuth) to Helicobacter pylori Eradication Protocols in a Clarithromycin Resistant and Tetracycline/Bismuth Naive Area: A Real-World Data Retrospective Analysis of 402 Cases (2016–24) in a Single Gastroenterology Unit. Antibiotics 2025; 14(9): 870 doi: 10.3390/antibiotics14090870
|
3 |
Adrian Bakiera, Anita Solarz, Marika Kowalczyk, Halina Cichoż-Lach, Izabela Korona-Głowniak. Challenges and Prospects for Eradication of Helicobacter pylori: Targeting Virulence Factors, Metabolism, and Vaccine Innovation. Pathogens 2025; 14(7): 619 doi: 10.3390/pathogens14070619
|